The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective observational study of sunitinib administered on schedule 2/1 in patients with metastatic renal cell carcinoma (mRCC): The rainbow study.
Sergio Bracarda
Consultant or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Boehringer Ingelheim; GlaxoSmithKline; Novartis; Pfizer
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Roberto Iacovelli
Consultant or Advisory Role - Bayer Schering Pharma; GlaxoSmithKline; Pfizer
Honoraria - Bayer Schering Pharma
Mimma Rizzo
No relevant relationships to disclose
Marta Rossi
No relevant relationships to disclose
Luca Galli
No relevant relationships to disclose
Giuseppe Procopio
Consultant or Advisory Role - Bayer Schering Pharma; GlaxoSmithKline; Pfizer
Honoraria - Bayer Schering Pharma; GlaxoSmithKline; Pfizer
Flavia Longo
No relevant relationships to disclose
Matteo Santoni
No relevant relationships to disclose
Franco Morelli
No relevant relationships to disclose
Giuseppe di Lorenzo
No relevant relationships to disclose
Camillo Porta
Consultant or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Boehringer Ingelheim; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Astellas Pharma; Bayer Schering Pharma; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer Schering Pharma; Novartis
Andrea Camerini
No relevant relationships to disclose
Sara Di Bella
No relevant relationships to disclose
Angelo Martignetti
No relevant relationships to disclose
Donatello Gasparro
No relevant relationships to disclose
Roberto Sabbatini
Consultant or Advisory Role - Bayer Schering Pharma; GlaxoSmithKline
Giovanni Luca Ceresoli
No relevant relationships to disclose
Alessandra Mosca
No relevant relationships to disclose
Daniele Santini
No relevant relationships to disclose
Luca Boni
No relevant relationships to disclose